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background: Periprocedural myocardial infarction (MI) is induced by several angiographic mechanisms. However, there are limited data on 
whether these mechanisms differentially affect clinical outcomes.
Methods: We pooled the databases from 10 stent trials using drug-eluting stents (DES). Periprocedural MI was classified according to its 
underlying angiographic mechanisms; type 1 (due to side-branch occlusion), type 2 (due to other angiographic complications), or type 3 (without 
angiographically identifiable causes).
results: Among 16,383 patients, 1,151 (7.0%) experienced periprocedural MI; 690 (59.9%) were driven by type 1 cause, 223 (19.4%) by type 
2 cause, and 238 (20.7%) by type 3 cause. Two-year mortality was higher in patients with periprocedural MI than in those without (3.6% vs. 2.0%, 
P=0.001). Significant differences in mortality were observed according to the angiographic mechanisms of MI (type 1: 2.8% vs. type 2: 6.1% vs. type 
3: 3.2%) (Figure). After multivariable adjustment, type 2 MI was significantly associated with an increased risk of mortality (hazard ratio [HR] 2.69; 
95% confidence interval [CI] 1.57-4.63), while type 1 and type 3 MI were not related with increased mortality (type 1: HR 1.08; 95% CI 0.67-1.73, 
and type 3: HR 1.27; 95% CI 0.94-1.72).
conclusions: Among patients receiving DES, periprocedural MI was associated with increased mortality and there was a substantial difference in 
mortality effect according to the underlying angiographic mechanisms.
 
